Listen to Article
No surprise to Trends Journal subscribers, who know that some two months ago we had forecast the COVID WAR would end late March, mid-April, now the Drug Lords are making it “official.”
Stéphane Bancel, the vaccine-billionaire CEO of Moderna, said in an interview Thursday that he believes the COVID-19 pandemic will burn itself out in 2022 and become endemic, raising the risk in the future for those over 50 and high-risk groups.
Bancel, who is worth about $5 billion, said the pandemic phase will likely end but the public will continue to need annual boosters to prevent “breakthrough” infections, according to the Financial Times.
He spoke about Moderna’s life after the COVID-19 pandemic since the company is a one-trick pony. The vaccine is the only product that Moderna ever distributed. He spoke about a new vaccine that can respond to the Omicron variant and a vaccine that combines the flu and COVID-19 as future revenue streams.
Bancel recently appeared on Fox Business and was asked by anchor Maria Bartiromo about reports that said COVID-19 had a “tiny chunk” of DNA that matched sequences that were patented by Moderna three years before the pandemic began during the company’s cancer research.
Mr. Bancel said his scientists are looking into the data to see their accuracy.
“As I have said before, the hypothesis of an escape from a lab by an accident, it’s possible, humans make mistakes,” he said. “So it is possible that the Wuhan lab in China was looking at virus enhancement or gene modification and then there was an accident, somebody was infected…it is possible.” (See “AMERICA’S PUBLIC HEALTH SYSTEM IS UTTERLY CORRUPT” and “BERKSHIRE BILLIONAIRE WHO MADE A FORTUNE INVESTING IN COMPANIES THAT CONTRIBUTED TO U.S. OBESITY EPIDEMIC ‘APPALLED’ BY THOSE WHO REFUSE COVID JAB.”).
Yearly Flu Vax/COVID Vax
Pfizer CEO Albert Bourla said in an interview in January that he envisions a world where COVID-19 becomes manageable like the flu, and only requires one jab each year.
Bourla said that the virus will never be eradicated from society and will always kill some percentage of the public each year. (See: “PFIZER DRUG LORD PUSHING YEARLY COVID JABS. CALLS THOSE WHO WON’T SWALLOW BULLSHIT, ‘CRIMINALS.’”)
Bancel said he is confident that Moderna’s mRNA platform will allow the company to bring new drugs to the public for a variety of diseases. He estimated that there is an 80 percent chance that COVID-19 will become endemic in 2022, the FT reported.
“We should be in a world where, between vaccination, boosting a natural infection—and, potentially, a less virulent virus—we might move to an endemic setting where it circulates in the community forever,” he said.
TRENDPOST: Remember when President Donald Trump declared a state of COVID emergency on Friday the 13th in March 2020, and when he compared his “Operation Warp Speed” jab to the U.S.’s race for the atomic bomb? Trump said he would employ “every plane, truck and soldier” to distribute doses.
Then go back to November/December 2020 when the Drug Lords were selling their line that two jabs from the Operation Warp Speed COVID Jab would provide a 96 percent efficacy rate.
However, as we wrote, what they promised did not happen: See "ISRAEL: COVID DRUG MUCH LESS EFFECTIVE THAN WHAT WE'VE BEEN SOLD," (27 Jul 2021) and our 12 October 2021 Trends Journal article, “NEW STUDIES PROVE: 96 VAX EFFICACY RATE WAS PURE BULLSHIT.”
TRENDPOST: Despite claims by the drug cartels of taking great risks and investing billions in research and development (and often in building new facilities), before ever seeing a dime in profit, the facts prove differently.
Not all of those investments are private funds. BioNTech, for example, received the equivalent of $397 million from the German government to put toward the development of a vaccine.
In return, the company is supplying it to low-income countries at cost. Nevertheless, BioNTech reported a net profit of $1.3 billion for the first three months of 2021.
Moderna was similarly subsidized by the U.S. government, receiving billions in funding. Goldman Sachs predicts that Moderna will take in $13.2 billion from its vaccine in 2021.
Support the Trends Journal with these great products